Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...

Health-care companies fell amid mixed earnings. Shares of Danaher, which makes tools and equipment for the biotech, life-sciences and diagnostics businesses, plunged by roughly 10% after it posted ...

Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity ...

Henry Schein receives $250 million strategic investment from KKR, making them largest non-index fund shareholder.

KKR is set to become the largest non-index fund shareholder in Henry Schein, acquiring a 12% stake through a $250 million investment.

Gunjan Kedia is set to take the helm of the nation's largest regional bank in mid-April, becoming its first woman CEO. Wells Fargo said that its 2022 consent order with the Consumer Financial ...

Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Finally, we have a deal from KKR which has made an investment in healthcare and dental care provider Henry Schein.

Henry Schein shares up on strategic investment from KKR, management appointments, share buyback, and preliminary results.